PCM
TRIB

Perritt Capital Management’s Trinity Biotech TRIB Stock Holding History

Perritt Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11,520
Closed -$761K – 229
2016
Q3 		$761K Sell
11,520
-100
-0.9% -$6.22K 0.19% 117
2016
Q2 		$659K Buy
11,620
+680
+6% +$38.3K 0.17% 125
2016
Q1 		$638K Buy
10,940
+380
+4% +$20.2K 0.16% 134
2015
Q4 		$621K Sell
10,560
-43,812
-81% -$2.59M 0.13% 143
2015
Q3 		$3.11M Buy
54,372
+3,260
+6% +$262K 0.65% 67
2015
Q2 		$4.62M Sell
51,112
-40
-0.1% -$3.46K 0.82% 38
2015
Q1 		$4.92M Sell
51,152
-20
-0% -$1.85K 0.87% 32
2014
Q4 		$4.48M Buy
51,172
+44,072
+621% +$3.8M 0.82% 41
2014
Q3 		$649K Sell
7,100
-100
-1% -$10.8K 0.12% 167
2014
Q2 		$829K Sell
7,200
-920
-11% -$109K 0.14% 156
2014
Q1 		$984K Sell
8,120
-1,880
-19% -$246K 0.16% 140
2013
Q4 		$1.26M Hold
10,000
– – 0.21% 123
2013
Q3 		$1.09M Hold
10,000
– – 0.21% 116
2013
Q2 		$842K Buy
+10,000
New +$829K 0.19% 119

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Perritt Capital Management's TRIB Position: Q4 2016 in Review

Perritt Capital Management sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 11,520 shares — an estimated $761K sold.

Perritt Capital Management first reported a position in TRIB in Q2 2013 and held it in 14 quarters. The position peaked at $4.92M in Q1 2015. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • Perritt Capital Management reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • Perritt Capital Management sold 11,520 Trinity Biotech shares in Q4 2016, an estimated $761K.
  • Perritt Capital Management first reported a position in Trinity Biotech in Q2 2013 and held it in 14 quarters.
  • Perritt Capital Management's Trinity Biotech position peaked at $4.92M in Q1 2015.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on Perritt Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.